There is one clinical trial.
To analyze the intubation with severe covid-19 pneumonia, the infection rate of anesthesiologist after intubation, and summarizes the experience of how to avoid the infection of anesthesiologist and ensure the safety of patients with severe covid-19 pneumonia.
Description: The data of Success rate of intubation with severe COVID-19 pneumonia patientsMeasure: Success rate of intubation Time: the time span between 1hour before intubation and 24h after intubation
Description: Infection rate of Anesthesiologist who performed the endotracheal intubation for severe COVID-19 pneumonia patientsMeasure: Infection rate of Anesthesiologist Time: the time span between 1hour before intubation and 14days after intubation
Description: Extubation time of intubated severe COVID-19 pneumonia patientsMeasure: Extubation time Time: the time span between 1hour before intubation and 30days after intubation
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports